Lv11
20 积分 2025-05-28 加入
Bevacizumab for Cerebral Radionecrosis: A Single-Center Experience
1小时前
待确认
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
1小时前
已完结
An Innovative Regimen Basing on HFRT/SBRT and RC48-ADC Coactivation for Salvage Therapy in Patients with HER2-Expressing Advanced Solid Tumors
1个月前
已完结
Radiation therapy, tissue radiosensitization, and potential synergism in the era of novel antibody-drug conjugates
1个月前
已完结
9MW2821, a next-generation Nectin-4 targeting antibody-drug conjugate, in patients with advanced solid tumors: a first-in-human, open label, multicenter, phase Ⅰ/Ⅱ study
3个月前
已完结
Molecular classification of hormone receptor-positive HER2-negative breast cancer
3个月前
已完结
Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer
3个月前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
3个月前
已完结
Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial
3个月前
已完结
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial
3个月前
已完结
皖公网安备34019202002308
